BlueKey Equity Partners Invests in USATherm
Company Offers Innovation in the Thermography Space
FOR IMMEDIATE RELEASE: October 30, 2019
HOLLYWOOD, Fla. – USATHERM, based in Aventura, Fla, has developed a cutting-edge tool that helps vascular specialists identify the source of superficial venous insufficiency quickly and accurately. Always in search of innovative leaders in technology and medicine, BlueKey Equity Partners (BKEP), a small to middle-market private equity firm, today announced the completion of its investment in USATHERM.
“We were so impressed with USATherm as a company as well as with its tool that literally puts clinical thermography in the palm of your hand,” said Amaury Cifuentes, CFP®, CMP®, and a BlueKey Equity partner. “The ThermPix product suite is the future of diagnostics for venous disease.”
Ariel Soffer, M.D., co-founder of USATHERM with David Wright, M.D., said, “Our vision for USATherm is to establish thermographic imaging as an element in the standard engagement protocol for patients with venous disease.”
Dr. Soffer is a board-certified cardiologist and pioneer in identifying venous disease within cardiovascular medicine. He is also the founder of Soffer Health Institute, one of the nation’s leading vein clinics, and founder of RxPhoto, a leading clinical photography platform. He also is an industry advisor with BlueKey Equity.
Dr. Wright is a board-certified vascular surgeon and member of the Royal Academy of Vascular Surgeons. He is the former Chief Scientific Officer for Varithena Division of BTG, now part of Boston Scientific.
About BlueKey Equity Partners
BlueKey Equity Partners specializes in small and mid-capital growth companies, leveraging the partnerships between investors, principals and communities. Its focus is on private lending, core real estate and business investment. The extensive experience of its professional team allows the firm to implement a rigorous process to identify the “Best in Class” opportunities in its focus areas. The company assists in providing capital, innovative solutions and strategic expertise to its portfolio throughout the investment cycle. For additional information, visit bluekeyequitypartners.com.
The founders of USATherm were seeking a more efficient approach to screen for chronic venous insufficiency and were ultimately led to thermography – a way to visualize insufficient vessels and to correlate them to ultrasound imaging. Our company vision is to establish thermographic imaging as an element in the standard engagement protocol for patients with venous disease.
For additional information contact: